PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) comprise a group of malignant tumors arising from the squamous epithelium of the oral cavity, pharynx, and larynx. HNSCC is the 6th most common cancer in the world, with approximately 650,000 new cases and 400,000 deaths annually. Although survival rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Siming, Wu, Changwu, Duan, Yingjuan, Fu, Jinfei, Wang, Yuling, Wu, Hao, Zhang, Bixi, Tang, Juyu, Wu, Panfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937984/
https://www.ncbi.nlm.nih.gov/pubmed/36820030
http://dx.doi.org/10.1016/j.heliyon.2023.e13479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937984/
https://www.ncbi.nlm.nih.gov/pubmed/36820030
http://dx.doi.org/10.1016/j.heliyon.2023.e13479

Ejemplares similares